SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Jim B who wrote (2208)6/30/1998 4:40:00 PM
From: Mr. Forthright  Respond to of 5402
 
The first question for the valuation model was:

1) What is the total market potential for synthetic red blood cell products?

Question number 2:

What kind of market share/penetration is SGNC expected to achieve?



To: Jim B who wrote (2208)6/30/1998 4:46:00 PM
From: SteelerStu  Respond to of 5402
 
I wish I had a deep pocket or a job at the US Mint right about now. I would be buying like crazy at .6875 and that goes for MTEI, INFE, and DGIV as well. These are yard sale prices. Don't miss the boat just cause of a little waves .. SteelerStu.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News